Acute Changes in Biomarkers of Potential Harm Following Electronic Cigarette Use: A Laboratory-Based Study
Nicotine & Tobacco Research · 20.11.2026
DOI: 10.1093/ntr/ntag244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine & Tobacco Research, online erschienen am 20.11.2026. Verfasst von Ali Nosseir und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Electronic cigarettes (e-cigarettes) are widely used for smoking cessation or harm reduction, but their potential long-term health effects remain uncertain. Biomarkers of potential harm (BOPH) can provide early insight into biological effects of exposure before clinical disease develops. We studied whether acute e-cigarette use alters circulating biomarkers related to inflammation, endothelial activation, and lung injury.
Methods
Twenty-three adult regular e-cigarette users participated in a two-arm counterbalanced crossover study, of whom 20 had complete data for both product conditions and were included in the primary analysis. On separate study days, participants used either their usual brand (UB) e-cigarette or a standardized research electronic cigarette (SREC) provided through the National Institute on Drug Abuse. Each study day included a 5-minute standardized vaping session followed by a 3-hour ad libitum use session. Plasma concentrations of IL-6, IL-8, ICAM-1, TNFR1, RAGE, and ANG2 were measured before and at various times after use. Biomarker responses were analyzed using repeated-measures analyses on log-transformed data.
Results
No significant changes were observed in any biomarkers after the standardized or ad libitum vaping sessions (all p > .05). Responses were similar between the SREC device and participants’ UB devices.
Conclusions
In regular e-cigarette users, acute vaping sessions did not produce significant changes in biomarkers of inflammation, endothelial activation, or epithelial injury. These findings indicate that short-term e-cigarette use in habitual vapers does not produce detectable acute systemic inflammatory responses. Whether longer-term vaping produces adverse changes in BOPH remains to be determined.
Zitieren
APA
Nosseir, A., Castellanos, E., Lawrence, L., Helen, G. S., Leroux, C., Matthay, M. A., Calfee, C. S., & Benowitz, N. L. (2026). Acute Changes in Biomarkers of Potential Harm Following Electronic Cigarette Use: A Laboratory-Based Study. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntag244
Vancouver
Nosseir A, Castellanos E, Lawrence L, Helen GS, Leroux C, Matthay MA, et al. Acute Changes in Biomarkers of Potential Harm Following Electronic Cigarette Use: A Laboratory-Based Study. Nicotine & Tobacco Research. 2026. doi:10.1093/ntr/ntag244
BibTeX
@article{Nosseir2026,
author = {Nosseir, Ali and Castellanos, Edgar and Lawrence, Lisa and Helen, Gideon St. and Leroux, Carolyn and Matthay, Michael A and Calfee, Carolyn S and Benowitz, Neal L},
title = {Acute Changes in Biomarkers of Potential Harm Following Electronic Cigarette Use: A Laboratory-Based Study},
journal = {Nicotine & Tobacco Research},
year = {2026},
doi = {10.1093/ntr/ntag244}
}
EUVIMED